Regional Anesthesia for Major Surgery of the Foot. Levobupivacaine 0.5% versus Ropivacaine 0.5% in the Sciatic Block Through mediofemorale.

Trial Profile

Regional Anesthesia for Major Surgery of the Foot. Levobupivacaine 0.5% versus Ropivacaine 0.5% in the Sciatic Block Through mediofemorale.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 07 Oct 2016

At a glance

  • Drugs Levobupivacaine (Primary) ; Ropivacaine
  • Indications Perioperative pain
  • Focus Therapeutic Use
  • Acronyms SCIALERO
  • Most Recent Events

    • 18 Sep 2012 Last checked against European Clinical Trials database.
    • 19 Aug 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top